Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng-Hsiang Lin

Showing results (241-250 of 252) with videos related to

Pageof 26
Sort By:
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|January 22, 2019
Postoperative Mycobacteroides abscessus subsp. abscessus endophthalmitis: Clinical analysis of 12 clustered adults and a proposed therapeutic algorithmJia-Horung Hung, Wen-Chien Ko, Chau-Yin Chen, et al.
European Journal of Medical Research|March 16, 2025
Lower body mass index is associated with the achievement of target LDL in patients using PCSK9 inhibitors in TaiwanKuan-Chieh Tu, Wei-Ting Chang, Hui-Wen Lin, et al.
BMC Nephrology|February 22, 2014
Shorter daily dwelling time in peritoneal dialysis attenuates the epithelial-to-mesenchymal transition of mesothelial cellsYi-Che Lee, Yau-Sheng Tsai, Shih-Yuan Hung, et al.
International Heart Journal|September 2, 2016
Analysis of the Clinical Characteristics, Management, and Causes of Death in Patients with ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention from 2005 to 2014Po-Tseng Lee, Ting-Hsing Chao, Ya-Ling Huang, et al.
Journal of Gastrointestinal Oncology|May 18, 2023
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in TaiwanJuei-Seng Wu, Tzu-Chun Hong, Hung-Tsung Wu, et al.
Pharmaceutics|November 11, 2022
Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular CarcinomaHsin-Yu Kuo, Meng-Zhi Han, Chih-Hsiang Liao, et al.
Therapeutic Advances in Medical Oncology|January 13, 2025
Comparing immunotherapy effectiveness for unresectable hepatocellular carcinoma: infiltrative versus non-infiltrative types in real-world settingsChien-Ming Chiang, Kuan-Kai Huang, Chun-Te Lee, et al.
Clinical Epigenetics|June 20, 2020
Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancerLi-Yun Ding, Ya-Chin Hou, I-Ying Kuo, et al.
Journal of Neurointerventional Surgery|August 28, 2025
Integrated drip-and-ship improves stroke transfer efficiency and outcomes: a comparison with traditional drip-and-ship and mothership modelsChun-Min Wang, Che-Wei Lin, Yu-Ming Chang, et al.
Cancers|February 11, 2023
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular CarcinomaHsueh-Chien Chiang, Yang-Cheng Lee, Ting-Tsung Chang, et al.
Pageof 26

Showing results (241-250 of 252) with videos related to

Sort By:
Pageof 26
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|January 22, 2019
Postoperative Mycobacteroides abscessus subsp. abscessus endophthalmitis: Clinical analysis of 12 clustered adults and a proposed therapeutic algorithmJia-Horung Hung, Wen-Chien Ko, Chau-Yin Chen, et al.
European Journal of Medical Research|March 16, 2025
Lower body mass index is associated with the achievement of target LDL in patients using PCSK9 inhibitors in TaiwanKuan-Chieh Tu, Wei-Ting Chang, Hui-Wen Lin, et al.
BMC Nephrology|February 22, 2014
Shorter daily dwelling time in peritoneal dialysis attenuates the epithelial-to-mesenchymal transition of mesothelial cellsYi-Che Lee, Yau-Sheng Tsai, Shih-Yuan Hung, et al.
International Heart Journal|September 2, 2016
Analysis of the Clinical Characteristics, Management, and Causes of Death in Patients with ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention from 2005 to 2014Po-Tseng Lee, Ting-Hsing Chao, Ya-Ling Huang, et al.
Journal of Gastrointestinal Oncology|May 18, 2023
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in TaiwanJuei-Seng Wu, Tzu-Chun Hong, Hung-Tsung Wu, et al.
Pharmaceutics|November 11, 2022
Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular CarcinomaHsin-Yu Kuo, Meng-Zhi Han, Chih-Hsiang Liao, et al.
Therapeutic Advances in Medical Oncology|January 13, 2025
Comparing immunotherapy effectiveness for unresectable hepatocellular carcinoma: infiltrative versus non-infiltrative types in real-world settingsChien-Ming Chiang, Kuan-Kai Huang, Chun-Te Lee, et al.
Clinical Epigenetics|June 20, 2020
Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancerLi-Yun Ding, Ya-Chin Hou, I-Ying Kuo, et al.
Journal of Neurointerventional Surgery|August 28, 2025
Integrated drip-and-ship improves stroke transfer efficiency and outcomes: a comparison with traditional drip-and-ship and mothership modelsChun-Min Wang, Che-Wei Lin, Yu-Ming Chang, et al.
Cancers|February 11, 2023
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular CarcinomaHsueh-Chien Chiang, Yang-Cheng Lee, Ting-Tsung Chang, et al.
Pageof 26